Sotera Health Co (SHC)

Return on assets (ROA)

Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020 Mar 31, 2020
Net income (ttm) US$ in thousands 44,388 70,746 40,098 54,857 51,376 -307,024 -268,274 -261,369 -233,570 122,146 124,500 136,681 116,882 37,205 9,771 -25,811 -38,617 -22,837 -28,482 -29,156
Total assets US$ in thousands 3,071,650 3,148,740 3,057,820 3,059,690 3,130,420 3,036,570 3,074,870 3,414,170 3,117,700 2,810,630 2,839,680 2,835,770 2,789,500 2,742,740 2,851,130 2,777,000 2,761,280 2,700,000 2,558,980
ROA 1.45% 2.25% 1.31% 1.79% 1.64% -10.11% -8.72% -7.66% -7.49% 4.35% 4.38% 4.82% 4.19% 1.36% 0.34% -0.93% -1.40% -0.85% -1.11%

December 31, 2024 calculation

ROA = Net income (ttm) ÷ Total assets
= $44,388K ÷ $3,071,650K
= 1.45%

The return on assets (ROA) of Sotera Health Co has shown fluctuations over the analyzed period. From June 2020 to September 2021, the ROA was negative, indicating that the company was not efficiently utilizing its assets to generate profits. However, there was a significant turnaround in the later quarters of 2021 and early 2022, with ROA improving to above 4%. This suggests that the company was able to generate higher profits relative to its total assets during this period.

Subsequently, the ROA declined sharply in the last quarter of 2022 and continued to decrease throughout 2023, reaching its lowest point at -10.11% in September 2023. This negative trend indicates that the company's profitability in relation to its assets worsened significantly during this period, possibly due to inefficiencies or other operational challenges.

In 2024, the ROA started to recover, showing a positive trend again, albeit at a lower level compared to the peak in early 2022. The slight fluctuations in ROA during 2024 indicate a period of relative stability in the company's asset utilization and profitability. Overall, the analysis of Sotera Health Co's ROA suggests that the company has experienced periods of both strong performance and challenges in optimizing its asset efficiency and profitability.


Peer comparison

Dec 31, 2024

Company name
Symbol
ROA
Sotera Health Co
SHC
1.45%
DaVita HealthCare Partners Inc
DVA
5.42%
Progyny Inc
PGNY
8.95%